Insights

Partnership Potential NeuExcell Therapeutics recently partnered with Spark Therapeutics, a subsidiary of Roche, demonstrating willingness to collaborate with established industry players. Leveraging this partnership can open doors for joint research endeavors or co-development opportunities.

Funding Boost Securing $15M in Series Pre-A+ financing indicates a healthy financial standing for NeuExcell Therapeutics and potential for further investments. This funding can be leveraged to scale operations, accelerate research initiatives, and explore new market opportunities.

Technology Adoption Utilizing a tech stack including MySQL, PHP, and Yoast SEO showcases NeuExcell's commitment to innovation. Highlighting the technological prowess of the company can appeal to tech-focused clients seeking advanced solutions in the biotechnology sector.

Disease Focus Advantage With a focus on neurodegenerative diseases like Huntington's disease and ALS, NeuExcell Therapeutics is positioned as a niche expert in tackling these challenging conditions. This specialization presents unique selling propositions to pharmaceutical companies or research institutions seeking breakthrough solutions.

Competitive Landscape Analysis By studying similar companies like Micro Medical Solutions and Resonetics with revenue ranges comparable to NeuExcell, sales teams can identify potential clients who might resonate with NeuExcell's offerings. Analyzing competition can help tailor sales pitches and strategies effectively.

NeuExcell Therapeutics Tech Stack

NeuExcell Therapeutics uses 8 technology products and services including MySQL, Twitter Emoji (Twemoji), Font Awesome, and more. Explore NeuExcell Therapeutics's tech stack below.

  • MySQL
    Database
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Font Awesome
    Font Scripts
  • core-js
    Javascript Libraries
  • Babel
    Miscellaneous
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security

NeuExcell Therapeutics's Email Address Formats

NeuExcell Therapeutics uses at least 1 format(s):
NeuExcell Therapeutics Email FormatsExamplePercentage
FirstLast@neuexcell.comJohnDoe@neuexcell.com
66%
FirstLa@neuexcell.comJohnDo@neuexcell.com
18%
FLast@neuexcell.comJDoe@neuexcell.com
10%
FirLast@neuexcell.comJohDoe@neuexcell.com
6%

Frequently Asked Questions

Where is NeuExcell Therapeutics's headquarters located?

Minus sign iconPlus sign icon
NeuExcell Therapeutics's main headquarters is located at 411 Swedeland Rd King of Prussia, Pennsylvania 19406 US. The company has employees across 2 continents, including North AmericaAsia.

What is NeuExcell Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
NeuExcell Therapeutics's official website is neuexcell.com and has social profiles on LinkedIn.

How much revenue does NeuExcell Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, NeuExcell Therapeutics's annual revenue reached $1.8M.

What is NeuExcell Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
NeuExcell Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NeuExcell Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, NeuExcell Therapeutics has approximately 12 employees across 2 continents, including North AmericaAsia. Key team members include Chief Business And Strategy Officer: L. G.Vice President Vp, Head Of Cmc And Tech Ops: Q. K. Y.Vice President , Head Of Cmc And Tech Ops: K. Y.. Explore NeuExcell Therapeutics's employee directory with LeadIQ.

What industry does NeuExcell Therapeutics belong to?

Minus sign iconPlus sign icon
NeuExcell Therapeutics operates in the Biotechnology Research industry.

What technology does NeuExcell Therapeutics use?

Minus sign iconPlus sign icon
NeuExcell Therapeutics's tech stack includes MySQLTwitter Emoji (Twemoji)Font Awesomecore-jsBabelPHPYoast SEOX-XSS-Protection.

What is NeuExcell Therapeutics's email format?

Minus sign iconPlus sign icon
NeuExcell Therapeutics's email format typically follows the pattern of . Find more NeuExcell Therapeutics email formats with LeadIQ.

When was NeuExcell Therapeutics founded?

Minus sign iconPlus sign icon
NeuExcell Therapeutics was founded in 2016.
NeuExcell Therapeutics

NeuExcell Therapeutics

Biotechnology ResearchPennsylvania, United States11-50 Employees

NeuExcell Therapeutics is a gene therapy company focusing on improving the lives of patients suffering from neurodegenerative diseases. We have discovered a disruptive technology that focuses on regenerating neurons in the brain. This powerful platform has the potential to transform patient outcomes and change lives.

We are now rapidly expanding our R&D efforts, toward our goal of developing effective and safe treatments for serious neurodegenerative diseases including stroke, Huntington’s Disease, ALS, and Traumatic Brain Injury.

Our experienced team is excited to dedicate themselves to contribute and bring innovative and effective treatments for those suffering from neurodegenerative conditions.

It is our goal to improve the quality of life of millions of patients worldwide by using the power of gene therapy to restore damaged neuronal tissue.

Section iconCompany Overview

Headquarters
411 Swedeland Rd King of Prussia, Pennsylvania 19406 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $10M

    NeuExcell Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    NeuExcell Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.